Zhongke Borui Secures Tens of Millions in Series A Funding Led by Aeonmed to Advance Innovative Brain Monitoring Devices

Feb 01, 2024 17:40 CST Updated 17:40

Casibrain Technology

Brain Diagnostic and Therapeutic Equipment Developer

Instrument Family

Pioneer in Medical Device Media Reports

Share Professional Medical Device Knowledge

Source: BioAngel

Recently,Casibrain (Beijing) Technology Co., Ltd. (hereinafter referred to as "Casibrain Technology") announced the completion of a multi-million yuan Series A strategic financing round.This round of financing was exclusively invested by Beijing Eage Medical Systems Co., Ltd. (hereinafter referred to as "Eage Medical"). The funds raised from this round of financing will be mainly used to accelerate the clinical trial process of multiple product lines, innovative product research and development, as well as marketing and sales efforts.

Casibrain Technology was incubated at the Institute of Automation, Chinese Academy of Sciences. By the director of the Brainnetome Center at the Institute of Automation, Chinese Academy of Sciences, and a foreign academician of the European Academy of Sciences.Researcher Jiang TianziChief Scientist, Key Technology Talent of the Chinese Academy of Sciences, High-end Leading Talent of ZhongguancunResearcher Zhang XinServing as the chairman and general manager. Relying on the guidance of researcher Tianzi Jiang, the team's Brainnetome Center has accumulated over 20 years of experience in the field of brain science. It has proposed significant achievements in brain science, such as a new human brainnetome atlas and a photoelectric synchronous brain activity detector, providing strong support for Casibrain Technology to develop comprehensive solutions in brain science.

Focusing on cerebrovascular diseases, a major category of neurological disorders, Casibrain Technology continues to deepen its research and accelerate the transformation of the National Key Scientific Instrument Development Project under the Ministry of Science and Technology – the Photoelectric Synchronous Brain Activity Imaging Device. This has led to the creation of the world's first integrated multimodal brain function imaging system that combines electroencephalography (EEG) with functional near-infrared spectroscopy (fNIRS). Through brain-computer interface technology, it aids in evaluating the therapeutic effects for rehabilitation patients.

Currently, Casibrain Technology has applied for and been granted more than 50 intellectual property rights. It has formed product directions such as "Brain Physiology," "Brain Consciousness," and "Brain Function," and launched a series of innovative devices, including non-invasive cerebral oxygen monitors, non-invasive whole-brain oxygen monitors, photoelectric synchronous multimodal brain imaging instruments, and intelligent brain diagnosis and research platforms. These products cover precise diagnosis and treatment of brain functional diseases and brain-computer feedback rehabilitation, transforming cutting-edge brain science technologies into clinically-oriented medical device products through engineering and industrialization.

Regarding this round of financing, Zhang Xin, founder of Casibrain Technology, stated: We would like to express our heartfelt gratitude to Aeonmed for recognizing Casibrain Technology. Aeonmed is a leading company in China specializing in the research, development, and manufacturing of anesthesia and respiratory medical devices. Its product portfolio spans six major business segments: respiratory and ICU, anesthesia and operating room, emergency and disaster response, laminar flow and hospital engineering, sleep and respiratory disorders, and IVD. Aeonmed’s products are not only innovative but also distributed through an extensive network covering almost all channels. Moving forward, Casibrain Technology will leverage Aeonmed's distribution and promotion channels to expand its product coverage from individual points to broader markets. In terms of product development, in addition to the innovative products already developed, Casibrain Technology will continue to focus on three key areas—'brain function monitoring,' 'brain function imaging,' and 'brain function treatment'—to develop innovative medical devices. Throughout this process, we hope to collaborate with more clinical experts to transform brain science technologies into innovative medical devices that meet the needs of various clinical scenarios, serving the diagnosis and treatment of patients with cerebrovascular diseases.

Deng Yongru, Vice General Manager of Yian Medical, saidIn recent years, brain function protection has become a clinical priority in the field of anesthesiology and intensive care units. Casibrain Technology, a company incubated by a renowned domestic and international brain science team, possesses inherent advantages in fundamental brain science research. At the same time, it focuses on the development of innovative devices for clinical scenarios. With its non-invasive cerebral oxygen monitor, the company quickly developed a highly competitive product and successfully entered the European hospital market. As a leading enterprise in the large-scale research, development, and manufacturing of anesthesia and respiratory medical devices, we will support the scaled promotion of Casibrain Technology’s products, accelerating their expansion from 1 to 100. Additionally, leveraging our years of experience in innovative product development, we will help promote more of Casibrain Technology's innovative products both domestically and internationally.

END

Powerful Partnership: Mindray Announces New Collaboration

Medical Device Giant: May Complete Spin-off in the First Half of 2024

$7.7 Billion: Cardiovascular Giant Plans to Sell Core Business

After Layoffs of 500, Medical Device Giant Sells Off This Product Line

Multiple Firsts in China, Brain Science Leader Plans IPO

Over 6.6 Billion: Mindray Medical Plans to Acquire Control of Huitai

The First Internet Healthcare Stock: 50% Layoffs?

After 21.1 Billion Merger, Orthopedic Giant "Reorganizes and Cuts Jobs"

Fourth Largest Globally, China-Based Leader Secures Strategic Financing of 900 Million Yuan

Beijing's Largest Hospital to Open: Mindray, United Imaging, GPS, and Others Win Bids

BusinessBusiness cooperation email: qxzj@landianyiliao.com